Ilya M. Nasrallah, MD, PhD

Radiology
Accepting new patients
Sees patients age 18 and up
Penn Medicine Provider

About me

  • Associate Professor of Radiology at the Hospital of the University of Pennsylvania

My education and training

  • Medical School: University of Pennsylvania School of Medicine
  • Residency: University of Pennsylvania Health System
  • Fellowship: University of Pennsylvania Health System

Spoken languages

English
English

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Penn Medicine Rittenhouse Long-Term Acute Care Hospital
  • Chester County Hospital: Has privileges to treat patients in the hospital.
Dr. Nasrallah is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Khandelwal P, Duong MT, Levorse LM, Trotman W, Bahena A, Lim SA, Denning AE, Chung E, Olm CA, Radhakrishnan H, Ittyerah R, Prabhakaran K, Mizsei G, Schuck T, Emrani S, Vizcarra JA, Robinson J, Ohm DT, Phillips JS, Cohen J, Wisse LEM, Detre JA, Nasrallah IM, Brown CA, Das SR, Lee EB, Tisdall MD, Irwin DJ, McMillan CT, Wolk DA, Yushkevich PA. Postmortem brain MRI reveals differential associations of subcortical and limbic volumes with cortical thinning and neurodegenerative pathologies , Alzheimers Dement, 22(7): 2026,e71649


Brown CA, Robinson JL, Das SR, McGrew E, Suh E, Van Deerlin VM, Irwin DJ, Nasrallah IM, Mechanic-Hamilton D, Yushkevich PA, Wolk DA, Lee EB. Clinicopathologic Evaluation of Amyloid Clearance in Alzheimer Disease , JAMA: 2026,e2613058


McKinstry D, Shi Z, Ramos-Rolón AP, Phillips J, Das S, Li X, Hager NM, Pond T, Volkow ND, Kranzler HR, Dubroff JG, Nasrallah IM, Wiers CE. Hippocampal Volume and Brain Tau Pathology in Opioid Use Disorder: Associations with Non-Fatal Opioid Overdose , Addict Neurosci, 19: 2026,100253


Mundada NS, Sadeghpour N, McGrew E, Tucker HL, Nasrallah IM, Das SR, Wolk DA, Yushkevich PA, Brown CA, Wisse LEM. Vulnerability of anterior medial temporal lobe subregions to early tau-related neurodegeneration in Alzheimer's disease: Converging evidence from tau-PET and plasma p-tau217 , Alzheimers Dement, 22(6): 2026,e71571


Torres MF, Charisis S, Rashid T, Brandigampala SR, Hiatt KD, Ware JB, Whitlow CT, Nasrallah IM, Romero JR, Tanley JE, Seshadri S, Hohman TJ, Heckbert SR, Davatzikos C, Hughes TM, Habes M. Comparative Analysis of Artificial Intelligence-Based Quantification versus Visual Rating of Enlarged Perivascular Spaces in the Multi-Ethnic Study of Atherosclerosis Cohort , AJNR Am J Neuroradiol, 47(5): 2026,1259-1265


Jiang X, Hoang TD, Shaw LM, Jacobs DR Jr, Nasrallah IM, Bryan RN, Yaffe K. Alzheimer's disease neuropathology plasma biomarkers and cognition in midlife: a community-based cohort study , Lancet, 407(10544): 2026,2208-2216


Xueying Lyu, Christopher A Brown, Michael Tran Duong, Emma P Fischer, Emily McGrew, David J Irwin, Bradford C Dickerson, Ilya M Nasrallah, Russell Takeshi Shinohara, Alexandra L Young, Paul A Yushkevich, Sandhitsu R Das, David A Wolk; Alzheimer's Disease Neuroimaging Initiative Uncovering distinct spatiotemporal trajectories of T-N mismatch subtypes with likely co-pathology in Alzheimer's disease using event-based modeling , Alzheimers Dement, 22(5): 2026,e71474


Lyu X, Mundada NS, Brown CA, Sadeghpour N, McGrew E, Xie L, Li Y, Wuestefeld A, Duong MT, Cook P, Gee J, Nasrallah IM, Chen-Plotkin AS, Shaw LM, Mechanic-Hamilton D, Wisse LEM, Yushkevich PA, Das SR, Wolk DA. Medial temporal lobe Tau-Neurodegeneration mismatch from structural imaging and plasma biomarkers , Brain: 2026,awag105


Skampardoni I, Erus G, Nasrallah IM, Yang Z, Duggan MR, Walker KA, Getka A, Baik K, Melhem R, Govindarajan ST, Resnick SM, Shou H, Nikita K, Davatzikos C. Coupled cross-sectional and longitudinal non-negative matrix factorization reveals dominant brain aging trajectories in 48,949 individuals , Nat Commun: 2026


Brown CA, Cousins KAQ, Korecka M, McGrew E, Chen-Plotkin A, Detre JA, McMillan CT, Lee EB, Das SR, Mechanic-Hamilton D, Yushkevich PA, Nasrallah IM, Shaw LM; Alzheimer's Disease Neuroimaging Initiative; Wolk DA. Temporal Modeling of Amyloid and Tau Trajectories in Alzheimer's Disease Using PET and Plasma Biomarkers , Ann Neurol: 2026